Seeyond’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.17M Sell
2,857
-1,516
-35% -$588K 0.11% 253
2022
Q3
$1.42M Sell
4,373
-218
-5% -$80.1K 0.17% 179
2022
Q2
$1.61M Buy
4,591
+578
+14% +$236K 0.18% 178
2022
Q1
$2.19M Buy
4,013
+980
+32% +$516K 0.22% 136
2021
Q4
$2M Sell
3,033
-7
-0.2% -$4.39K 0.19% 177
2021
Q3
$1.89M Sell
3,040
-713
-19% -$479K 0.18% 171
2021
Q2
$2.37M Buy
3,753
+17
+0.5% +$9.39K 0.22% 133
2021
Q1
$1.83M Sell
3,736
-1,254
-25% -$628K 0.18% 183
2020
Q4
$2.49M Buy
4,990
+480
+11% +$215K 0.26% 97
2020
Q3
$1.77M Buy
4,510
+88
+2% +$32.5K 0.19% 150
2020
Q2
$1.46M Buy
4,422
+3,191
+259% +$924K 0.17% 188
2020
Q1
$171K Sell
1,231
-8
-0.6% -$2.09K 0.02% 508
2019
Q4
$324K Hold
1,239
0.03% 489
2019
Q3
$337K Hold
1,239
0.04% 473
2019
Q2
$341K Sell
1,239
-1,574
-56% -$388K 0.04% 483
2019
Q1
$629K Sell
2,813
-1,073
-28% -$222K 0.06% 432
2018
Q4
$723K Buy
+3,886
New +$797K 0.1% 303

Other funds holding IDXX

Seeyond's IDXX Position: Q4 2022 in Review

Seeyond reduced its Idexx Laboratories (IDXX) stake by 35% in Q4 2022, selling an estimated $588K and leaving 2,857 shares worth $1.17M. The position accounts for 0.11% of the portfolio, ranked #253.

Seeyond first reported a position in IDXX in Q4 2018 and has held it in 17 quarters since. The position peaked at $2.49M in Q4 2020. 1,000 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

  • Seeyond held 2,857 shares of Idexx Laboratories worth $1.17M as of Q4 2022.
  • Seeyond sold 1,516 Idexx Laboratories shares in Q4 2022, an estimated $588K.
  • Idexx Laboratories made up 0.11% of Seeyond's portfolio in Q4 2022, its #253 holding.
  • Seeyond first reported a position in Idexx Laboratories in Q4 2018 and has held it in 17 quarters since.
  • Seeyond's Idexx Laboratories position peaked at $2.49M in Q4 2020.
  • 1,000 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.